About Powerhouse Therapeutics Inc
Powerhouse Therapeutics is a biotechnology company focused on developing cell therapies to treat deadly cancers, particularly through its proprietary IT-ACTS platform and lead candidate PH102, which targets solid tumors like liver cancer.
Development of cell therapies for cancer treatmentEngineering of immune superchargers using the IT-ACTS platformTargeting of solid tumors, including liver cancer (hepatocellular carcinoma)Modular platform for both autologous and allogeneic cell therapiesReprogramming of tumor immune microenvironments to enhance immune cell activity
Is this your company?
Claim Powerhouse Therapeutics Inc to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim Powerhouse Therapeutics Inc & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.